Does method of sternal repair influence long-term outcome of postoperative mediastinitis?

Am J Surg. 2011 Nov;202(5):565-7. doi: 10.1016/j.amjsurg.2011.06.013. Epub 2011 Sep 14.

Abstract

Background: Post-sternotomy mediastinitis reduces survival after cardiac surgery, potentially further affected by details of mediastinal vascularized flap reconstruction. The aim of this study was to evaluate survival after different methods for sternal reconstruction in mediastinitis.

Methods: Two hundred twenty-two adult cardiac surgery patients with post-sternotomy mediastinitis were reviewed. After controlling infection, often augmented by negative pressure therapy, muscle flap, omental flap, or secondary closure was performed. Outcomes were reviewed and survival analysis was performed.

Results: Baseline characteristics were similar. In-hospital mortality (15.7%) did not differ between groups. Secondary closure was correlated with negative pressure therapy and reduced length hospital of stay. Recurrent wound complications were more common with muscle flap repair. Survival was unaffected by sternal repair technique. By multivariate analysis, heart failure, sepsis, age, and vascular disease independently predicted mortality, while negative pressure therapy was associated with survival.

Conclusions: Choice of sternal repair was unrelated to survival, but mediastinal treatment with negative pressure therapy promotes favorable early and late outcomes.

MeSH terms

  • Adult
  • Age Factors
  • Anti-Bacterial Agents / therapeutic use
  • Cardiovascular Surgical Procedures / adverse effects
  • Debridement
  • Heart Failure / epidemiology
  • Hospital Mortality
  • Humans
  • Length of Stay
  • Mediastinitis / etiology*
  • Mediastinitis / mortality
  • Mediastinitis / therapy*
  • Mediastinum / microbiology
  • Mediastinum / surgery
  • Multivariate Analysis
  • Negative-Pressure Wound Therapy
  • Retrospective Studies
  • Sepsis / epidemiology
  • Sternotomy / adverse effects*
  • Sternum / surgery
  • Surgical Flaps
  • Vascular Diseases / epidemiology

Substances

  • Anti-Bacterial Agents